Explore Watchlists Pricing

Edwards Lifesciences Corp (EW) Balance sheet

Market cap

$45.9B

P/E ratio

43.2x

Summary Financials

Income statement Balance sheet Cash flow Other

	2010/12	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	396	171	311	420	654	718	930	818	714	1,179	1,200	867	773	1,148	3,059	2,940
Total cash & short-term investments	396	171	311	420	654	718	930	818	714	1,179	1,200	867	773	1,148	3,059	2,940
Accounts receivable, net	277	284	321	303	288	315	366	422	457	544	515	582	643	775	609	660
Inventories	204	261	281	309	297	340	397	555	607	641	802	727	876	1,168	1,087	1,126
Total current assets	1,033	1,169	1,292	1,726	2,295	2,048	2,240	2,532	2,287	2,984	3,091	3,181	3,096	4,036	6,285	6,739
Property, plant and equipment, net	270	304	373	422	443	483	580	680	868	1,060	1,395	1,547	1,633	1,749	1,686	1,812
Marketable securities, non-current	25	22	21	22	241	380	532	567	506	586	802	1,834	1,239	584	308	279
Total non-current assets	-	-	-	-	-	-	-	-	-	1,242	1,608	1,749	1,725	1,843	1,784	1,915
Total assets	1,767	1,981	2,222	2,725	3,524	4,059	4,510	5,696	5,324	6,488	7,237	8,503	8,293	9,363	13,055	13,697
Accounts payable	48	85	75	48	58	64	97	117	134	180	197	205	202	201	197	228
Long-term debt, current	-	-	-	-	-	-	-	598	-	-	-	-	-	-	-	-
Total current liabilities	338	335	347	346	434	476	533	1,403	877	902	894	1,032	1,022	1,195	1,505	1,814
Long-term debt, non-current	-	-	-	593	598	600	822	438	594	594	595	596	596	597	598	598
Total liabilities	-	-	-	-	-	-	-	-	-	-	-	2,667	2,486	2,644	2,992	3,360
Retained earnings	1,124	1,361	1,654	2,046	2,842	3,337	3,906	1,962	2,695	3,742	4,565	6,068	7,590	8,992	13,167	14,241
Stockholders' equity	1,308	1,338	1,479	1,559	2,191	2,503	2,619	2,956	3,140	4,148	4,574	5,836	5,807	6,719	10,063	10,338
Working capital